Key regulatory challenges in developing modified new chemical drugs in China: a national survey study

ObjectiveWith the increasing number of modified new chemical drugs (MNCDs) entering the market or in the approval pipeline in China, understanding their current status is crucial. This study aims to present stakeholders’ perspectives on the R&D and regulatory challenges associated with MNCDs...

Full description

Saved in:
Bibliographic Details
Main Authors: Lixia Fu, Guoshu Jia, Minji Wei, Yimin Cui
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1576013/full
Tags: Add Tag
No Tags, Be the first to tag this record!